Country: United States
Language: English
Source: NLM (National Library of Medicine)
BRYONIA ALBA ROOT (UNII: T7J046YI2B) (BRYONIA ALBA ROOT - UNII:T7J046YI2B)
Apotheca Company
BRYONIA ALBA ROOT
BRYONIA ALBA ROOT 12 [hp_X] in 1 g
OTC DRUG
unapproved homeopathic
BRYONIA - BRYONIA, PELLET APOTHECA COMPANY _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- BRYONIA 12X ACTIVE INGREDIENTS: Bryonia 12X. USE: Pain care: use like aspirin or Tylenol. WARNINGS: If conditions persist, contact your doctor. When pregnant or nursing, seek councel. Keep out of kids' reach. Do not use if cap band is missing. DIRECTIONS: Dissolve or swallow 4 pellets adults or 2 pellets children. Take every half hour, or 6-7 times per day. INACTIVE INGREDIENTS: Sucrose, Lactose. KEEP OUT OF KIDS' REACH. USE: Pain care: use like aspirin or Tylenol. HISTORICAL REMEDIES 122 S. Wabasha, Saint Paul, MN 55107 TOLL FREE: 800-676-6654 100 Homeopathic Dose BRYONIA Bryonia alba HPUS 12X PAIN CARE HISTORICAL REMEDIES BRYONIA bryonia, pellet PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:57520 -0 727 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH BRYO NIA ALBA RO O T (UNII: T7J0 46 YI2B) (BRYONIA ALBA ROOT - UNII:T7J0 46 YI2B) BRYONIA ALBA ROOT 12 [hp_X] in 1 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SUCRO SE (UNII: C151H8 M554) LACTO SE (UNII: J2B2A4N9 8 G) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:57520 -0 727-1 15 g in 1 BOTTLE MARKETING INFORMATION Apotheca Company MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved ho meo pathic 0 6 /23/20 11 LABELER - Apotheca Company (844330915) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS Apo theca Co mpany 8 44330 9 15 ma nufa c ture Revised: 6/2011 Read the complete document